AIVITA Biomedical Announces New Clinical Data in Ongoing Phase 2 Brain Cancer Trial

IRVINE, Calif., July 8, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today new clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA’s platform immunotherapy targeting cancer stem cells. Blood plasma biomarker analyses have identified predictive markers of efficacy in seven of eight treated … Continued

Read More

ClearFlow Announces Positive Randomized Controlled Trial Results and Inclusion in ERAS Guideline Recommendations

ANAHEIM, Calif.–(BUSINESS WIRE)– ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results of its PleuraFlow® device were presented at the American Association for Thoracic Surgery (AATS) 99th Annual meeting on May 4 in Toronto, Canada. This new data stems from a trial evaluating the use of ClearFlow’s PleuraFlow®Active Clearance Technology® (ACT®) System … Continued

Read More

AIVITA Biomedical Presents New Clinical Data at 2019 ASCO Annual Meeting

IRVINE, Calif., June 3, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that Chief Medical Officer Dr. Robert O. Dillman presented clinical data on melanoma patients treated with patient-specific vaccines on June 1 at the 55th Annual Meeting of ASCO in Chicago, Illinois. The data is being … Continued

Read More

AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy

AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy   Findings suggest a combination with checkpoint inhibitors will enhance response rate beyond 72% survival, and facilitate a new Phase 1B approval   IRVINE, Calif., Feb. 12, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell … Continued

Read More

The Hottest Enterprise Tech Startups to Watch in 2019

  #MariaDB momentum is heating up! @computerworlduk lists #MariaDB as one of the hottest enterprise tech startups in the world. http://ow.ly/I7fU30nAud5   Who are the hottest enterprise tech startups in the world? MariaDB as an open source database contender made the list by Computerworld UK. http://ow.ly/I7fU30nAud5   The hottest enterprise tech startups to watch in 2019   … Continued

Read More

Philips Recognized by Frost & Sullivan for Its Integrated Medication Adherence System, PMAS

Philips Recognized by Frost & Sullivan for Its Integrated Medication Adherence System, PMAS NEWS PROVIDED BY Frost & Sullivan  08:00 ET By connecting patients, pharmacists, caregivers, and providers, the PMAS delivers patient care in a decentralized format SANTA CLARA, Calif., Dec. 5, 2018 /PRNewswire/ — Based on its recent analysis of the North American medication adherence market, Frost … Continued

Read More

ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan

ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan IRVINE, Calif., Nov. 28, 2018 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Company’s revolutionary stem-cell based ROOT OF SKIN™ skincare line sold out at launch on the Japanese home shopping channel QVC Japan. … Continued

Read More

AIVITA Biomedical Consumer Skincare Line ROOT OF SKIN™ to Be Sold on Home Shopping Channel QVC Japan

AIVITA Biomedical Consumer Skincare Line ROOT OF SKIN™ to Be Sold on Home Shopping Channel QVC Japan IRVINE, Calif., Oct. 30, 2018 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today it has executed a deal to sell the Company’s ROOT OF SKIN™ line of rejuvenating skincare products … Continued

Read More

AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial

AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial IRVINE, Calif., Nov. 16, 2018 /PRNewswire/ — AIVITA Biomedical announced today that it has dosed the first two patients in its Phase 2 clinical trial in patients with newly diagnosed glioblastoma. The trial is designed to investigate AIVITA Biomedical’s next-generation patient-specific cancer … Continued

Read More

AIVITA Biomedical Appoints Paul Jenkinson and Philippe Schaison to its Board of Directors

AIVITA Biomedical Appoints Paul Jenkinson and Philippe Schaison to its Board of Directors IRVINE, Calif. – October 23, 2018 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, has announced the appointment of two new members to its Board of Directors. Paul Jenkinson, former Chief Financial Officer at Kite Pharma, Inc., … Continued

Read More